Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Apr 16 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding its investment in Feldan Therapeutics to enhance intracellular drug delivery innovation. The investment aims to support the development of treatments for conditions like basal cell carcinoma and respiratory diseases using Feldan's proprietary technology. Dr. Sharvil Patel of Zydus emphasized the commitment to advancing novel therapeutics to improve patient quality of life through this partnership. Zynext Ventures, the investment arm of Zydus, will provide strategic guidance and financial support to Feldan.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 16, 2025, titled "Zynext Ventures Invests in Feldan Therapeutics to Drive Innovation in Intracellular Drug Delivery".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases